SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ArQule
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
399 14 0 ARQL
Emcee:  noronha Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
124 <A> ArQule, Inc. and Ontogeny, Inc. Announce Collaboration for Discovery SteveG-12/18/1997
123 <...Companies tend to save up major announcements for the Hambrecht and QuisSteveG-12/15/1997
122 ArQule will be the leadoff presenter at the January H&Q conference. They wiDr. John M. de Castro-12/10/1997
121 The Sankyo deal is worth $30-$35 million to ARQL. This information wasn't iDr. John M. de Castro-11/18/1997
120 Margie: Nice deal....... Japanese pharmas are jumping into combichem of latscaram(o)uche-11/17/1997
119 Sankyo Company, Ltd. and ArQule, Inc. Execute a Broad Three Year Collaboration margie-11/17/1997
118 Yet Another ARQL Collaboration! biz.yahoo.com John de CDr. John M. de Castro-11/6/1997
117 Thanks for the press release. The collaborations keep coming. Improvement in eaWally Mastroly-10/21/1997
116 Another ARQL Collaboration! These guys are getting their fingers into everythinDr. John M. de Castro-10/20/1997
115 ARQL 3Q97 EPS = + $.02, see link: biz.yahoo.comWally Mastroly-10/17/1997
114 So what do you think? I think I should have bought more last time this stock fThe Prophet-10/10/1997
113 At this rate ArQule will be collaborating with every other biotech company in aDr. John M. de Castro-10/9/1997
112 ArQule, Inc. and RiboGene, Inc. Announce Collaboration for Discovery and DeveloDoug Baer-10/9/1997
111 For once, science, humanity, and investors share a common goal. I feel like a The Prophet-9/18/1997
110 Prophet: I consider it to be a very strong possibility, yes. That's why sscaram(o)uche-9/18/1997
109 Do you think, potentially, that ARQL could get a share of a superdrug, e.g., AIThe Prophet-9/18/1997
108 Prophet: The deals are set. The question is, who will get to the <proprietscaram(o)uche-9/17/1997
107 These types of competition sections will generalize any industry and pretty mucJames Silverman-9/17/1997
106 No. That's a good idea.The Prophet-9/17/1997
105 Have you read the "Competition" section of their most recent 10-K?WWS-9/17/1997
104 I've read up on the company. I'm just not sure whether their model is The Prophet-9/17/1997
103 Prophet, I would suggest contacting ARQL and obtaining an investors packet. James Silverman-9/17/1997
102 Welcome to the world of biotech. ;-) Rickscaram(o)uche-9/16/1997
101 Darn. And here I was actually thinking that they were going to make money withThe Prophet-9/16/1997
100 No. ArQule has no products.scaram(o)uche-9/16/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News